News
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...
1d
MedPage Today on MSNFDA Chief Defends Job Cuts, COVID Booster Policy at Senate HearingSeven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
1d
India Today on MSNCovid-19 vaccine rules may change from 2025: What you should knowThe FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...
Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...
Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results